TherapeuticsMD, Inc.TXMDNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank20
3Y CAGR-70.1%
5Y CAGR-62.1%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-70.1%/yr
vs -16.4%/yr prior
5Y CAGR
-62.1%/yr
Recent deceleration
Acceleration
-53.7pp
Decelerating
Percentile
P20
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$1.52M-
2024$0.00-
2023$0.00-100.0%
2022$56.71M-22.0%
2021$72.75M-62.5%
2020$194.01M+11.0%
2019$174.72M+50.6%
2018$115.99M+101.0%
2017$57.70M+12.4%
2016$51.35M-